These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

359 related articles for article (PubMed ID: 29932012)

  • 1. Choroideremia: molecular mechanisms and development of AAV gene therapy.
    Patrício MI; Barnard AR; Xue K; MacLaren RE
    Expert Opin Biol Ther; 2018 Jul; 18(7):807-820. PubMed ID: 29932012
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pathogenicity of a novel missense variant associated with choroideremia and its impact on gene replacement therapy.
    Torriano S; Erkilic N; Faugère V; Damodar K; Hamel CP; Roux AF; Kalatzis V
    Hum Mol Genet; 2017 Sep; 26(18):3573-3584. PubMed ID: 28911202
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of induced pluripotent stem cell models to probe the pathogenesis of Choroideremia and to develop a potential treatment.
    Duong TT; Vasireddy V; Ramachandran P; Herrera PS; Leo L; Merkel C; Bennett J; Mills JA
    Stem Cell Res; 2018 Mar; 27():140-150. PubMed ID: 29414605
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reduced Retinal Pigment Epithelial Autophagy Due to Loss of Rab12 Prenylation in a Human iPSC-RPE Model of Choroideremia.
    Raeker MÖ; Perera ND; Karoukis AJ; Chen L; Feathers KL; Ali RR; Thompson DA; Fahim AT
    Cells; 2024 Jun; 13(12):. PubMed ID: 38920696
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Functional expression of Rab escort protein 1 following AAV2-mediated gene delivery in the retina of choroideremia mice and human cells ex vivo.
    Tolmachova T; Tolmachov OE; Barnard AR; de Silva SR; Lipinski DM; Walker NJ; Maclaren RE; Seabra MC
    J Mol Med (Berl); 2013 Jul; 91(7):825-37. PubMed ID: 23756766
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adeno-associated virus 8-mediated gene therapy for choroideremia: preclinical studies in in vitro and in vivo models.
    Black A; Vasireddy V; Chung DC; Maguire AM; Gaddameedi R; Tolmachova T; Seabra M; Bennett J
    J Gene Med; 2014; 16(5-6):122-30. PubMed ID: 24962736
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adeno-Associated Viral Gene Therapy for Inherited Retinal Disease.
    Ong T; Pennesi ME; Birch DG; Lam BL; Tsang SH
    Pharm Res; 2019 Jan; 36(2):34. PubMed ID: 30617669
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Choroideremia: molecular mechanisms and therapies.
    Sarkar H; Moosajee M
    Trends Mol Med; 2022 May; 28(5):378-387. PubMed ID: 35341685
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gene Augmentation of CHM Using Non-Viral Episomal Vectors in Models of Choroideremia.
    Toualbi L; Toms M; Almeida PV; Harbottle R; Moosajee M
    Int J Mol Sci; 2023 Oct; 24(20):. PubMed ID: 37894906
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gene therapy for choroideremia using an adeno-associated viral (AAV) vector.
    Barnard AR; Groppe M; MacLaren RE
    Cold Spring Harb Perspect Med; 2014 Oct; 5(3):a017293. PubMed ID: 25359548
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CHM/REP1 cDNA delivery by lentiviral vectors provides functional expression of the transgene in the retinal pigment epithelium of choroideremia mice.
    Tolmachova T; Tolmachov OE; Wavre-Shapton ST; Tracey-White D; Futter CE; Seabra MC
    J Gene Med; 2012 Mar; 14(3):158-68. PubMed ID: 22228595
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular Therapy for Choroideremia: Pre-clinical and Clinical Progress to Date.
    Kalatzis V; Roux AF; Meunier I
    Mol Diagn Ther; 2021 Nov; 25(6):661-675. PubMed ID: 34661884
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Technique of retinal gene therapy: delivery of viral vector into the subretinal space.
    Xue K; Groppe M; Salvetti AP; MacLaren RE
    Eye (Lond); 2017 Sep; 31(9):1308-1316. PubMed ID: 28820183
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Retinal pigment epithelium defects accelerate photoreceptor degeneration in cell type-specific knockout mouse models of choroideremia.
    Tolmachova T; Wavre-Shapton ST; Barnard AR; MacLaren RE; Futter CE; Seabra MC
    Invest Ophthalmol Vis Sci; 2010 Oct; 51(10):4913-20. PubMed ID: 20445111
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Is subretinal AAV gene replacement still the only viable treatment option for choroideremia?
    Han RC; Fry LE; Kantor A; McClements ME; Xue K; MacLaren RE
    Expert Opin Orphan Drugs; 2021; 9(1):13-24. PubMed ID: 34040899
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Remodeling of the human retina in choroideremia: rab escort protein 1 (REP-1) mutations.
    Jacobson SG; Cideciyan AV; Sumaroka A; Aleman TS; Schwartz SB; Windsor EA; Roman AJ; Stone EM; MacDonald IM
    Invest Ophthalmol Vis Sci; 2006 Sep; 47(9):4113-20. PubMed ID: 16936131
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comprehensive mutation analysis (20 families) of the choroideremia gene reveals a missense variant that prevents the binding of REP1 with Rab geranylgeranyl transferase.
    Esposito G; De Falco F; Tinto N; Testa F; Vitagliano L; Tandurella IC; Iannone L; Rossi S; Rinaldi E; Simonelli F; Zagari A; Salvatore F
    Hum Mutat; 2011 Dec; 32(12):1460-9. PubMed ID: 21905166
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modeling Choroideremia Disease with Isogenic Induced Pluripotent Stem Cells.
    Fonseca AF; Coelho R; da-Silva ML; Lemos L; Hall MJ; Oliveira D; Falcão AS; Tenreiro S; Seabra MC; Antas P
    Stem Cells Dev; 2024 Oct; 33(19-20):528-539. PubMed ID: 39078329
    [TBL] [Abstract][Full Text] [Related]  

  • 19. AAV-mediated gene therapy for choroideremia: preclinical studies in personalized models.
    Vasireddy V; Mills JA; Gaddameedi R; Basner-Tschakarjan E; Kohnke M; Black AD; Alexandrov K; Zhou S; Maguire AM; Chung DC; Mac H; Sullivan L; Gadue P; Bennicelli JL; French DL; Bennett J
    PLoS One; 2013; 8(5):e61396. PubMed ID: 23667438
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of CRISPR/Cas9 exon-skipping vector for choroideremia using human induced pluripotent stem cell-derived RPE.
    Iwagawa T; Masumoto H; Tabuchi H; Tani K; Conklin BR; Watanabe S
    J Gene Med; 2023 Feb; 25(2):e3464. PubMed ID: 36413603
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.